Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.
A research project by Griffith University’s Institute for Glycomics seeks to identify and develop new drugs and a vaccine to...
Researchers announce two new treatments with potential to prevent and cure gonorrhoea.
A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby...
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), has announced awards...
Public health problem takes on 'superbug' status
Advanced bionic limb development, malaria drug mechanisms, skin immune response to mosquito-borne infections among new Ideas Grants.
Vaginal microbes are at the centre of a novel discovery that aims to investigate if these bacteria trap HIV or act as a courier service to deliver the virus to the host within the human body.
We are delighted to share some successful outcomes for NHMRC Investigator Fellowships announced on 12 October 2022 by the National Health and Medical Research Council (NHMRC).
Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.
